Neurolens

About Neurolens

Neurolens is a company focused on providing therapeutic lenses that offer life-changing relief from symptoms of eye misalignment such as headaches, motion sickness, neck pain, and eye strain. Their mission is to restore comfortable vision through innovative, non-invasive, and cost-effective solutions.

Products & Services

Neurolenses:Therapeutic lenses with contoured prism technology to relieve symptoms of eye misalignment like headaches, neck pain, motion sickness, and eye strain. Available in Single Vision, Office, and Progressive designs for all ages.

Specialties

Therapeutic Lenses Contoured Prism Technology Eye Misalignment Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Growth Capital T: - FT: Growth Capital	A: 45000000 MR: - FA: $45 million FAN: 45000000	D: 2023-12-05 FD: 2023-12-05	1 investors

Growth Capital Latest

2023-12-05

$45.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Neurolens Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised